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a-Aryl malonates represent an important class of molecules that have
various pharmaceutical applications. a-Aryl malonates have been used
as effective modulators in mammalian cell membranes and as enzyme
inhibitors (Gorssman and Varner, 1997). Malonate chemistry is the
best way to synthesize highly functionalized compounds containing
quaternary centers. (Canet et al., 1992; Martin, 1980) a-Aryl malonatesare used to synthesize a wide range of valuable intermediates in organic
chemistry. One of these important intermediates leads to synthesis of
a-aryl carboxylic acids (Toone and Jones, 1991; Shunsaku et al.,
1996; Narisano and Riva, 1999; Guanti et al., 1998; Chenevert and
Desjardins, 1994; Knabe et al., 1987; Meester et al., 1986).
a-Aryl acids represent an important class of molecules that are
found in numerous natural products, as well as find various pharma-
ceutical applications (Sheldrick et al., 1978; Kong and Andersen,
1993; Hedge et al., 1998). a-Aryl acids are used for synthesis of
different nonsteroidal anti-inflammatory drugs. For example, a-Aryl
acetic acids and a-aryl propionic acids are used for synthesis of
indomethacin, sulindac, ibufenac & diclofenac and ibuprofen,
naproxen & ketoprofen, respectively (Rieu et al., 1986).
Several methods for the synthesis of a-aryl acids have been
reported in literature; these include palladium-catalyzed cross coupling
of enolates with aryl halides (Culkin and Hatrwig, 2003; Aramendia
et al., 2002; Djakovitch and Kohler, 2000), as well as Cu(I)-catalyzed
arylation of diethyl malonate in the presence of proline (Xie et al.,
Scheme 1 Synthesis of substituted 2,3-benzodiazepine (A), substituted pyrrolopyridine ester (B) and substituted isoquinoline (C)
scaffolds.
Table 1 Reagents and conditions for the arylation of diethyl malonate (DEM) with substituted iodobenzene.
R
I
EtOOC COOEt+ Catalyst/ Ligand/ Base
Solvent/ Temp
EtOOC
COOEt
R
1a-d 2 3a-d
R; a=COOCH3; b=benzoyl; c= 4-methoxy benzoyl; d=nitrile
Entry Catalyst Ligand Solvent Temp. before
adding DEM
Temp (C) Time (h) Yield (%)a
1a 1b 1c 1d 3a 3b 3c 3d
1 No catalyst No ligand Dioxane r.t. r.t. 3 7 7 6 No reaction
2 No catalyst No ligand Dioxane 90 90 3 7 7 6 No reaction
3 CuI Picolinic acid Dioxane r.t. r.t. 3 14 14 6 6 5 8 8
4 CuI Picolinic acid Dioxane 90 90 3 7 7 6 71 63 80 84
5 CuI Picolinic acid Dioxane r.t. 90 3 7 7 6 76 69 89 86
6 CuI No ligand Dioxane 90 90 3 7 7 6 14 12 11 14
7 CuI No ligand DCE r.t. 90 3 7 7 6 No reaction
8 CuI No ligand DMF r.t. 90 3 7 7 6 No reaction
9 CuI Picolinic acid Toluene r.t. 90 3 7 7 6 78 69 90 89
10 Cu powder Picolinic acid Dioxane r.t. 90 3 7 7 6 77 70 90 90
11 Cu powder Picolinic acid Toluene r.t. 90 3 7 7 6 80 72 90 91
12 AuCl3 Picolinic acid Dioxane r.t. 90 3 7 7 6 5 4 6 5
13 Ag(CF3CO2) Picolinic acid Dioxane r.t. 90 3 7 7 6 No reaction
14 Cu(OTf)2 Picolinic acid Dioxane r.t. 90 3 5 5 6 83 75 91 94
15 Cu(OTf)2 Picolinic acid Toluene r.t. 90 3 5 5 6 85 76 91 94
16 Cu(OTf)2 Picolinic acid Toluene r.t. M.W 90 0.5 0.5 0.5 0.5 86 75 91 95
a Isolated yield.
S1974 M.A. Ibrahim2005; Buchwald, 2005). Nonetheless, several protocols may suffer seri-
ous limitations such as long reaction times, use of expensive metal cat-
alysts, and low reactivity of pyridyl halides or halobenzonitriles toward
palladium catalysts (Jiang et al., 2005; Fox et al., 2000; Culkin and
Hartwig, 2001; Katz and Aube, 2003; Richon et al., 1982; Shiotani
et al., 1996). Along with the lack of versatility in preparing such
a-aryl malonates, the arylation of activated methylene compounds in
the presence of copper metal or copper salts, known as Hurtley reac-
tion, is only effective for o-bromobenzoic acid and its closely related
halides (Hurtley, 1929). Reports on the Cu-mediated arylation of mal-
onates and their derivatives by aryl halides indicate that often a stoi-
chiometric amount of Cu complex is required; in addition, highreaction temperatures should be attained to allow the reaction to take
place. Furthermore, good yields are only achieved in the case of highly
activated aryl halides (Setsune et al., 1982; Suzuki et al., 1983, 1987).
However, milder reaction conditions have been achieved as described
by Buchwald, who reported the synthesis of a variety of arylated mal-
onates from aryl iodides using CuI and 2-phenylphenol monodentate
as a supporting ligand (Hennessy and Buchwald, 2002).
As a result of the importance of a-aryl malonates as intermediates
for synthesis of a wide array of pharmaceutical agents, we developed
an alternative general method that provides feasible access to a wide
number of a-aryl malonates in short reaction time. Herein, we show
the various optimization studied (bases, catalysts, ligands, solvents,
Table 2 Reagents and conditions for the arylation of diethyl malonate (DEM) with substituted bromopyridine.
bromopyridine.
N
Br
EtOOC COOEt+
Catalyst/ Ligand/ Base
Solvent/ Temp
COOEt
COOEtN
4a,b 2 5a,b
R R
COOEtN
6a,b
+
R; a=H; b=Methyl
Entry Catalyst Ligand Solvent Temp. before adding DEM Temp. (C) Time (h) Yield (%)a
5a+ 6a 5b+ 6b
1 No catalyst No ligand Dioxane r.t. r.t. 14 No reaction
2 No catalyst No ligand Dioxane 90 90 14 No reaction
3 CuI Picolinic acid Dioxane r.t. r.t. 14 No reaction
4 CuI Picolinic acid Dioxane 90 90 7: 65% of 5a 35% of 5a
14: 70% of 5a+ 15% of 6a 39% of 5a+ 5% of 6a
5 CuI Picolinic acid Dioxane r.t. 90 7: 85% of 5a 43% of 5a
14: 80% of 5a+ 10% of 6a 40% of 5a+ 6% of 6a
6 CuI No ligand Dioxane 90 90 14 No reaction
7 CuI No ligand DCE r.t. 90 14 No reaction
8 CuI No ligand DMF r.t. 90 14 No reaction
9 CuI Picolinic acid Toluene r.t. 90 7: 87% of 5a 45% of 5a
14: 80% of 5a+ 10% of 6a 41% of 5a+ 6% of 6a
10 CuI Picolinic acid Toluene/MgSO4 r.t. 90 7: 88% of 5a 46% of 5a
14: 81% of 5a+ 11% of 6a 42% of 5a+ 6% of 6a
11 Cu powder Picolinic acid Dioxane r.t. 90 7: 88% of 5a 47% of 5a
14: 81% of 5a+ 11% of 6a 42% of 5a+ 7% of 6a
12 Cu powder Picolinic acid Toluene/MgSO4 r.t. 90 7: 88% of 5a 47% of 5a
14: 81% of 5a+ 10% of 6a 43% of 5a+ 7% of 6a
13 AuCl3 Picolinic acid Dioxane r.t. 90 14 No reaction
14 Ag(CF3CO2) Picolinic acid Dioxane r.t. 90 14 No reaction
15 Cu(OTf)2 Picolinic acid Dioxane r.t. 90 7: 89% of 5a 52% of 5a
14: 83% of 5a+ 11% of 6a 47% of 5a+ 9% of 6a
16 Cu(OTf)2 Picolinic acid Toluene/MgSO4 r.t. 90 7: 91% of 5a 54% of 5a
14: 84% of 5a+ 12% of 6a 49% of 5a+ 11% of 6a
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S1976 M.A. Ibrahimreaction times, reaction temperatures and leaving halides) toward the
a-arylation of diethyl malonate. In addition, we employed the pre-
pared a-aryl malonates for the synthesis of benzodiazepine, isoquino-
line and pyrrolopyridine scaffolds.
2. Results and discussion
In a typical experiment, the desired aryl halides (1 mmole),
cesium carbonate (3 mmole), copper triflate (0.1 mmole) and
picolinic acid (0.2 mmole) were mixed together and flushed
with argon. Anhydrous toluene was added followed by diethyl
malonate (2 mmole). The mixture was irradiated in microwave
at 90 C for 30 min (Scheme 1).
Firstly, we investigated the a-arylation of diethyl malonate
on substituted iodo benzene (methyl 2-iodobenzoate,
2-iodobenzophenone, 2-iodo 4-methoxybenzophenone and
2-iodobenzonitrile) (Table 1). In all cases, cesium carbonate
was chosen as the base. In the absence of any catalyst/ligand,
microwave irradiation resulted in no successful arylation
(entries 1, 2). On the other hand, this reaction was sluggish
at room temperature, even in the presence of various copper
catalysts, picolinic acid as a ligand (entry 3). Indeed, heating
at 90 C in the presence of the aforementioned reagents
resulted in better yields where diethyl malonate is later added
to the reaction mixture (entries 4, 5). With respect to solvent
effect, both 1,4-dioxane and toluene showed comparable effi-
ciency (entries 5, 9, 10, 11, 14, 15). However, the presence of
the ligand is critical given that low yield is obtained when no
ligand was added in a solution of 1,4-dioxane while no reaction
was observed when DCE or DMF was used (entries 6, 7, 8).
When comparing the various metal catalysts, only copper salts
(Cu powder, CuI and copper triflate) showed excellent conver-
gent results (entries 5, 9, 10, 11, 14, 15), while auric chloride
indicated little reaction progress and silver trifluoroacetate
(AgCF3CO2) was entirely ineffective (entries 12, 13).
Finally, shorter reaction times were achieved when micro-
wave oven was used in place of conventional heating methods.
Indeed, optimum results can be obtained when Cs2CO3, cop-
per triflate, and picolinic acid were used as additives in toluene
at 90 C for 30 min (entry 16).
Next, we aimed at investigating the scope of the arylation of
diethyl malonate with N-heterocyclic compounds, namely,
2-bromopyridine and 2-bromo-5-methylpyridine (Table 2).
In all the following reaction trials, we used cesium carbon-
ate as a base. The reaction resulted in no successful arylation in
the presence of other bases (ALO-, Ba(OH)2, NaH). The reac-
tion did not work without any catalyst or ligand (entries 1, 2).
Doing the reaction at room temperatures using copper salts as
a catalyst, picolinic acid as a ligand and cesium carbonate as a
base did not show a good progress (entry 3). The reaction did
not work in the absence of picolinic acid in different solvents
(dioxane, DCE, DMF) (entries 6–8).
a-Arylation of diethyl malonate on 2-bromopyridine 4a for
7 h yielded 5a in 65–91% yield while arylation of 2-bromo-5-
methylpyridine 4b for the same period afforded 5b in 35–
55% yield according to the employed conditions. On the other
hand, longer reaction times using either 4a or 4b as a starting
material (14 h) results in a mixture of 5a and 6a, and 5b and 6b,
respectively (entry 5). Similarly, solvents with different polarity
(dioxane, toluene, acetonitrile) were examined; toluene showed
the best results especially upon addition of MgSO4 as a drying
agent (entries 10, 12, 16, 18). Acetonitrile exhibited almost
Microwave-assisted synthesis of malonates S1977similar results as toluene (entry 17). Auric chloride and silver
salt did not show any reaction progress (entries 13, 14).
Copper salts (Cu powder, CuI and copper triflate) in toluene/
MgSO4 showed the best results (entries 10, 12, 16). Microwave
irradiation has been used to optimize the reaction conditions.
The reaction proceeded in the presence of cesium carbonate,
Cu(OTf)2 and picolinic acid in toluene/MgSO4 under micro-
wave irradiations for 30 min to give 5a in 91% yield (entry 18).
Increasing the irradiation time to 1 h gives mixture of 5a and
6a in 84% and 12% yields respectively. (entry 18).
Next, we tested the arylation of diethyl malonate on
2-chloro-3-nitropyridine, 2-chloro-5-nitropyridine and 2,6-
dichloro-3-nitropyridine (Table 3). In all the following reaction
trials, we used cesium carbonate as a base. The reaction has
been progressed at room temperature without ligand and cat-
alyst due to presence of electron withdrawing group (nitro
group) (entry 1). Heating the reaction at 90 C gives almost
the same results but with shorter reaction time (entry 2). Using
picolinic acid ligand and the copper salt catalyst and stirring at
room temperature for 2 h improves the yield (entries 3, 6, 8)
while heating the previous mixture gives better yields than stir-
ring at room temperature (entries 5, 7, 9). Different positions
of the nitro group in either the ortho (7a) or the para (7b) posi-
tions did not show significant difference in the reaction yield
(entry 10). The best reaction result has been obtained when
we used microwave. The reaction proceeds well in the presenceTable 3 Reagents and conditions for the arylation of diethyl malon
N
R1
Cl
R2
R3 EtOOC COOEt
Cataly
Sol
7a-c
+
2
7a
7b
7c
R1 R2 R3
NO2
NO2
H H
H H
NO2 H Cl
Entr y Catalyst Ligand Solvent Temp. before adding D
1 No catalyst No ligand Toluene r.t.
2 No catalyst No ligand Toluene r.t.
3 CuI Picolinic acid Toluene r.t.
5 CuI Picolinic acid Toluene r.t.
6 Cu powder Picolinic acid Toluene r.t.
7 Cu powder Picolinic acid Toluene r.t.
8 Cu(OTf)2 Picolinic acid Toluene r.t.
9 Cu(OTf)2 Picolinic acid Toluene r.t.
10 Cu(OTf)2 Picolinic acid Toluene r.t.
a Isolated yield.of cesium carbonate, copper triflate, and picolinic acid in
toluene at 90 C for 20 min (entry 10). Cesium carbonate
worked at room temperature for only 60 min with high yield
while other bases in the literature need high temperatures for
long time (Shirude et al., 2013; Li, 2011; Dunn et al., 2009;
Frank et al., 2013; Alam et al., 2013).
Different reaction conditions have been investigated for
arylation of diethyl malonate on 2,6-dichloro-3-nitropyridine.
When the reaction is performed at room temperature, it gives
only one product (entries 1, 3, 6, 8). Heating the reaction mix-
ture under different conditions gives mixture of the monoary-
lated product in high yield and the diarylated product in low
yield (entries 5, 7, 9, 10).
After screening different reaction conditions on synthesis of
a-aryl derivatives of diethyl malonate, we found that using cat-
alytic amount of Cu(OTf)2, 2-picolinic acid and Cs2CO3 in
toluene using microwave irradiation is the ideal condition.
Under these conditions, the reaction gives high yields in short
reaction time.
The devised protocol overcomes some drawbacks in the
literature including long reaction time, low yields, and poor
reactivity of aryl bromide, and is applicable toward substrates
containing certain functional groups in the ortho position (e.g.,
–NO2, –CN) (Hennessy and Buchwald, 2002).
As our research interest involves the preparation and study
of azaheterocycles (Elagawany et al., 2013; Ibrahim et al.,ate (DEM) with substituted chloropyridine.
N
R1R2
R3
COOEt
COOEtst/ Ligand/ Base
vent/ Temp
8a-d
8a
8b
8c
NO2
NO2
H H
H H
NO2 H
COOEt
COOEt
Cl
HNO28d
R1 R2 R3
EM Temp. (C) Time (h) Yield (%)a
7a 7b 7c 8a 8b 8c+ 8d
r.t. 2 2 2 70 69 60% 8c
90 1 1 1 73 70 65% 8c
r.t. 2 2 2 75 72 68% 8c
90 1 1 1 80 79 70% 8c+ 20% 8d
r.t 2 2 2 76 72 69% 8c
90 1 1 1 81 80 71% 8c+ 22% 8d
r.t. 2 2 2 85 85 75% 8c
90 1 1 1 88 90 75% 8c+ 21% 8d
M.W 90 0.2 0.2 0.2 87 90 75% 8c+ 22% 8d
Scheme 2 Synthesis of benzodiazepine derivatives 12a,b and isoquinoline scaffold 13.
S1978 M.A. Ibrahim2013, 2012), we employed the prepared a-aryl malonate in the
synthesis of benzodiazepine, isoquinoline and pyrrolopyridine
scaffolds (Scheme 1).
Firstly, the role of a-aryl malonate in the synthesis of 2,3-
benzodiazepine-4-one and isoquinoline scaffolds has been
described. Commercially available 2-iodobenzoic acid was
activated into the corresponding aroyl chloride which is then
involved in a Friedel–Crafts reaction in the presence of ben-
zene to give 1b or methoxybenzene to give 1c. Then, we synthe-
sized a-Aryl malonate derivatives 3b,c by our optimized
condition using diethyl malonate, copper-triflate and picolinic
acid in toluene in microwave for 30 min. a-Aryl malonate
derivatives were then decarboxylated in alkaline medium in
microwave at 120 C for 5 min in mixture of methanol and
water to give the decarboxylated form 10a,b. Condensation
of the decarboxylated intermediate 10a,b with hydrazine
hydrate gives the corresponding 2,3-benzodiazepines-4-one
11a,b while coupling the decarboxylated intermediate 10a with
tert-butyl-carbazate using EDCI, triethylamine and HOBt in
dimethylformamide at room temperature for 7 h gives iso-
quinoline scaffold 13. N-methylation of the amide function
in compound 11a was eventually performed with chloro-2-
methoxy ethane and benzyl chloride in the presence of Cs2CO3
and tetrahydrofuran to give compounds 12a,b. Our methodol-
ogy for synthesis of 2,3 benzodiazepine derivatives is more
time saving and gives higher yield (29% overall yield, 8.5 h)
than literature method (14% overall yield, more than 3 days)
(Mcdonald and Dunstone, 2006; Flammang and Wermuth,
1976) (Scheme 2).Further, the importance of a-aryl malonate in the synthesis
of 1-imino-2,3 benzodiazepine-4-one and substituted 1-imino-
isoquinoline has been described. (Scheme 3) A copper-
catalyzed reaction was performed on 2-iodobenzophenone
leading to the substitution of the iodine atom by a diethyl
malonate moiety using our optimized methodology in the
presence of copper-triflate and picolinic acid in toluene in
microwave for 30 min. Alkaline hydrolysis of a-aryl malonate
3d in microwave at 120 C for 5 min in mixture of methanol
and water gives the decarboxylated form 14. Coupling the
decarboxylated intermediate with benzyl tert-butyl-carbazate
15 using BOP, triethylamine in dichloromethane at room tem-
perature for 7 h gives compound 16 which is then deprotected
by trifluoroacetic acid at room temperature for 10 min to
compound 17. Several trials were performed for intramolecu-
lar cyclization of the deprotected form 17 between the amino
group and the nitrile group to obtain 1-imino-2,3
benzodiazepine-4-one 18. The reaction has been investigated
in trifluoroacetic acid at different temperature degrees starting
from room temperature to 130 C. Microwave irradiation of
compound 17 in trifluoroacetic acid for 30 min at 135 C gives
compound 18 in 10% yield. Also, we tried to use isopropanol
and butanol as solvents for intramolecular cyclization at
135 C for 24 h but the yield was 5%. Coupling reaction of
compound 14 with tert-butyl carbazate 19 in the presence of
BOP and triethylamine at room temperature for 7 h gives
the unseparated compound 20 which then attacks another
molecule of compound 14 to give compound 21 in 83%
(Scheme 3).
Scheme 3 Synthesis of 1-imino 2,3 benzodiazepine 18 and 1-imino isoquinoline 21 scaffolds.
Scheme 4 Synthesis of pyrrolopyridine ester 22.
Microwave-assisted synthesis of malonates S1979Furthermore, a-aryl malonate has been used in synthesis of
pyrrolopyridine scaffold. Our optimized copper-catalyzed
reaction was performed on the commercially available
2-chloro-3-nitropyridine to give 8a. Cyclization of compound
8a in acetic acid 100% and iron in microwave at 130 C for
15 min gives pyrrolopyridine ester 22. Our methodology for
synthesis of pyrrolopyridine ester is more time saving and
gives higher yield (82% overall yield, 35 min) than literature
method (10% overall yield, 13 h) (Dogan et al., 2015)
(Scheme 4).
3. Conclusion
In conclusion, an efficient and simple method to synthesize the
a-aryl diethyl malonates in good yields and shorter reaction
time is described. The optimized condition is achieved by using
catalytic amounts of copper triflate, picolinic acid and Cs2CO3in toluene using microwave irradiation. Then, a-aryl malonate
was employed as intermediate for the synthesis of benzodi-
azepines, isoquinolines and pyrrolopyridine scaffolds.
Currently, efforts toward the synthesis of new scaffolds using
a-aryl malonates are underway.
4. Experimental
All materials from commercial suppliers were used as pur-
chased. The melting points reported are uncorrected. 13C
NMR spectra were recorded on a Bruker Avance 400 spec-
trometer operating at 100 MHz. 1H NMR spectra were
recorded on a Bruker 300 MHz Avance DPX; probe dual.
Chemical shifts are given in parts per million (ppm) relative
to tetramethylsilane (TMS), and coupling constants J are given
in Hertz. Mass spectra were determined by ESI–mass spectra
obtained on an LC/MS instrument (AGILENT, MS:
S1980 M.A. IbrahimMSD-SL, LC: 1200SL). For MW reactions, irradiation was
performed using a Biotage Initiator EXP.
5. General procedure for a-arylation of diethyl malonate
The corresponding arylhalides 1a–d or 4a,b or 7a–c
(0.620 mmole), cesium carbonate (615 mg, 1.860 mmole), cop-
per triflate (22 mg, 0.062 mmole), picolinic acid (15 mg,
0.124 mmole) were mixed together and flushed with argon.
Anhydrous toluene (2 mL) was added followed by diethyl mal-
onate (195 lL, 1.240 mmole). The mixture was irradiated by
microwave at 90 C for 30 min. After completion of the reac-
tion, the solvent was evaporated under reduced pressure and
the residue was diluted with ethyl acetate and washed with
ammonium chloride, saturated solution of sodium bicarbonate
and brine solution. The organic layer was dried over anhy-
drous sodium sulfate and evaporated under reduced pressure.
The residue was purified by column chromatography using
gradient of ethyl acetate/heptane to give the corresponding
arylated malonate 3a–d or 5a,b or 6a,b or 8a–d respectively.
Diethyl 2-(2-(methoxycarbonyl)phenyl)malonate (3a):
(Setsune et al., 1981) Starting reactant (1a). Oily (86%); Purifi-
cation eluent; ethyl acetate/heptane 15%. 1H NMR (CDCl3)
d 1.27 (t, J= 7 Hz, 6H), 1.74 (s, 3H), 4.15–4.29 (m, 4H),
5.10 (s, 1H), 7.41–7.46 (m, 1H), 7.59–7.71 (m, 3H).
Diethyl 2-(2-benzoylphenyl)malonate (3b): (Kobayashi et al.,
1994) Starting reactant (1b). Oily (75%); Purification eluent;
ethyl acetate/heptane 15%. 1H NMR (CDCl3) d 1.62
(t, J= 7 Hz, 6H), 4.09–4.18 (m, 4H), 5.05 (s, 1H), 7.33–7.42
(m, 4H), 7.47–7.60 (m, 3H), 7.73–7.76 (m, 2H). 13C NMR
(CDCl3) d 14.0, 54.4, 61.8, 127.3, 128.4, 129.8, 130.2, 130.4,
131.0, 132.6, 133.3, 137.7, 138.4, 168.2, 197.5.
Diethyl 2-(2-(4-methoxybenzoyl)phenyl)malonate (3c): Start-
ing reactant (1c). Oily (91%); Purification eluent; ethyl acetate/
heptane 15%. 1H NMR (CDCl3) d 1.18 (t, J= 7 Hz, 6H), 3.84
(s, 3H), 4,09–4,20 (m, 4H), 5.00 (s, 1H), 6.88–6.91 (m, 2H),
7.35–7.36 (m, 2H), 7.47–7.62 (m, 2H), 7.74–7.77 (m, 2H). 13C
NMR (CDCl3) d 14.1, 55.7, 61.9, 113.8, 127.4, 129.3, 130.2,
130.5, 130.6, 132.3, 133.0, 139.1, 163.9, 168.4, 195.8.
Diethyl 2-(2-cyanophenyl)malonate (3d): (Beugelmans et al.,
1982) Starting reactant (1d). Oily (95%); Purification eluent;
ethyl acetate/heptane 20%. 1H NMR (CDCl3) d 1.22
(t, J= 7 Hz, 6H), 4.10–4.25 (m, 4H), 5.05 (s, 1H), 7.36–7.41
(m, 1H), 7.54–7.66 (m, 3H). 13C NMR (CDCl3) d 14.2, 55.7,
62.5. 113.7, 117.3, 128.8, 130.1, 133.0, 133.1, 136.3, 166.9.
5.1. Diethyl 2-(pyridin-2-yl)malonate (5a) + Ethyl 2-(pyridin-
2-yl)acetate (6a)
Using our generalized procedure gives mixture of 5a+ 6a:
Starting reactant (4a).
Diethyl 2-(pyridin-2-yl)malonate (5a): (Bob et al., 2009)
Oily; Purification eluent; ethyl acetate/heptane 30%. 1H
NMR (CDCl3) d 1.26 (t, J= 7 Hz, 6H), 4.20–4.36 (m, 4H),
4.93 (s, 1H), 7.20–7.28 (m, 1H), 7.48 (d, J= 7.9 Hz, 1H),
7.69 (t, J= 7.5 Hz, 1H), 8.55 (d, J= 4.3 Hz, 1H).
Ethyl 2-(pyridin-2-yl)acetate (6a): (Firth et al., 2014) Oily;
Purification eluent; ethyl acetate/heptane 30%. 1H NMR
(CDCl3) d 1.24 (t, J= 7.2 Hz, 3H), 3.82 (s, 2H), 4.17
(q, J= 7.2 Hz, 2H), 7.14–7.29 (m, 2H), 7.63 (t, J= 8.5 Hz,
1H), 8.54 (d, J= 4.3 Hz, 1H).Diethyl 2-(5-methylpyridin-2-yl)malonate (5b) + Ethyl 2-(5-
methylpyridin-2-yl)acetate (6b): (Beigelman et al., 2009; Akio,
2007) Using our generalized procedure gives mixture of 5b
+ 6b: Starting reactant (4b).
Diethyl 2-(5-methylpyridin-2-yl)malonate (5b): (Beigelman
et al., 2009) Oily; Purification eluent; ethyl acetate/heptane
30%. 1H NMR (CDCl3) d 1.25 (t, J= 7.2 Hz, 6H), 2.31
(s, 3H), 4.21–4.23 (m, 4H), 7.36 (d, J= 8.4 Hz, 1H), 7.51
(d, J= 8 Hz, 1H), 8.37 (d, J= 1.6 Hz, 1H).
Ethyl 2-(5-methylpyridin-2-yl)acetate (6b): (Akio, 2007)
Oily; Purification eluent; ethyl acetate/heptane 30%. 1H
NMR (CDCl3) d 1.24 (t, J= 7.2 Hz, 3H), 2.29 (s, 3H), 3.78
(s, 2H), 4.15 (q, J= 7.2 Hz, 2H), 7.16 (d, J= 8.0 Hz, 1H),
7.44 (dd, J= 7.8 Hz, 2 Hz, 1H), 8.36 (s, 1H).
Diethyl 2-(3-nitropyridin-2-yl)malonate (8a): (Shirude et al.,
2013) Oily; Purification eluent; ethyl acetate/heptane 30%. 1H
NMR (CDCl3) d 1.25 (t, J= 7.2 Hz, 6H), 4.21–4.30 (m, 4H),
5.49 (s, 1H), 7.49–7.53 (m, 1H), 8.46 (d, 1H, J= 8.3 Hz, 1H),
8.77 (d, J= 4.7 Hz, 1H).
Diethyl 2-(5-nitropyridin-2-yl)malonate (8b): (Frank et al.,
2013) Oily; Purification eluent; ethyl acetate/heptane 30%.
1H NMR (CDCl3) d 1.27 (t, J= 7.2 Hz, 6H), 4.21–4.29
(m, 4H), 5.04 (s, 1H), 7.74 (d, 1H, J= 8.6 Hz), 8.48
(dd, J= 8.7 Hz, 2.7 Hz, 1H), 9.36 (d, J= 2.5 Hz, 1H).
5.2. Diethyl 2-(6-chloro-3-nitropyridin-2-yl)malonate (8c) +
Tetraethyl 2,20-(3-nitropyridine-2,6-diyl)dimalonate (8d)
Our generalized procedure gives mixture of 8c+ 8d: Starting
reactant (7c).
Diethyl 2-(6-chloro-3-nitropyridin-2-yl)malonate (8c): (Alam
et al., 2013) Oily; Purification eluent; ethyl acetate/heptane
30%. 1H NMR (CDCl3) d 1.24 (t, J= 7.2 Hz, 6H),
4.10–4.14 (m, 4H), 5.39 (s, 1H), 7.74 (d, 1H, J= 8.6 Hz),
8.39 (d, 1H, J= 8.6 Hz).
Tetraethyl 2,20-(3-nitropyridine-2,6-diyl)dimalonate (8d):
Oily; Purification eluent; ethyl acetate/heptane 30%. 1H
NMR (CDCl3) d 1.21–1.27 (m, 12H), 4.16–4.30 (m, 8H),
4.94 (s, 1H), 5.46 (s, 1H), 7.74 (d, 1H, J= 8.6 Hz), 8.47
(d, 1H, J= 8.6 Hz). 13C NMR (CDCl3) d 14.1, 14.2, 59.6,
60.3, 62.3, 62.6, 124.6, 134.1, 148.5, 157.1, 166.3, 168.1,
168.4. Anal. calcd. for C19H24N2O10: C, 51.82; H, 5.49; N,
6.36; found: C, 51.83; H, 5.48; N, 6.35.
5.3. General procedure for synthesis of compounds 10a,b
A mixture of compounds 3b or 3c (0.58 mmole) and Lithium
hydroxide (74.1 mg, 1.761 mmole) in methanol (2 mL) and
water (1 mL) was irradiated in microwave at 120 C for
5 min. The mixture was then diluted with saturated solution
of Na2CO3 (20 mL) and extracted with ethyl acetate (20 mL).
The aqueous layer was then acidified with conc. HCl to PH
2 and extracted by ethyl acetate (3  20 mL). The organic layer
was dried over anhydrous sodium sulfate, filtered and evapo-
rated under reduced pressure to give compound 10a or 10b.
2-(3-Benzoylphenyl)acetic acid (10a): (Mcdonald and
Dunstone, 2006) White microcrystal, m.p. = 105–107 C
(85%) 1H NMR (CD3OD) d 3.86 (s, 2H), 7.34–7.53 (m, 6H),
7.58–7.63 (m, 1H), 7.75–7.77 (m, 2H). 13C NMR (CD3OD)
d 39.6, 127.7, 129.5, 131.1, 131.5, 132.2, 133.2, 134.3, 135.9,
139.2, 139.7, 174.9, 200.1.
Microwave-assisted synthesis of malonates S19812-(2-(4-Methoxybenzoyl)phenyl)acetic acid (10b):
(Flammang and Wermuth, 1976; Tang et al., 2010; Dogan
et al., 2015) White microcrystal, m.p. = 124–126 C (80%)
1H NMR (CD3OD) d 3.79 (s, 2H), 3.88 (s, 3H), 7.00
(d, J= 8.9 Hz, 2H), 7.37–7.42 (m, 3H), 7.48–7.52 (m, 1H),
7.77 (d, J= 8.9 Hz, 2H).
5.4. General procedure for synthesis of compounds 11a,b
A mixture of 10a or 10b (1.23 mmole) and hydrazine hydrate
(119.7 lL, 3.71 mmole) in isopropanol (2 mL) was irradiated
in microwave for 1 h at 140 C. The mixture was diluted in ethyl
acetate andwashedwith saturated solution of sodium bicarbon-
ate. The organic layer was purified by column chromatography
using ethyl acetate/heptane 1:1 to give compound 11a or 11b.
1-Phenyl-2,3-benzodiazepin-4(3H)-one (11a): (Mcdonald
and Dunstone, 2006; Flammang and Wermuth, 1976) White
microcrystal, m.p. = 217–219 C (65%) 1H NMR (CDCl3)
d 3.61 (s, 2H), 7.23–7.63 (m, 9H), 9.20 (s, 1H). 13C NMR
(CDCl3) d 42.3, 127.0, 128.2, 128.5, 129.4, 129.7, 130.1,
131.4, 132.0, 136.3, 136.0, 162.2, 171.3. m/z: 237 (m+1).
1-(4-Methoxyphenyl)-2,3-benzodiazepin-4(3H)-one (11b):
White microcrystal, m.p. = 232–234 C (70%) 1H NMR
(CDCl3) d 3.50 (s, 2H), 3.79 (s, 3H), 6.86 (d, J= 8.9 Hz,
2H), 7.17–7.19 (m, 1H), 7.24–7.32 (m, 2H), 7.43–7.50
(m, 3H), 8.64 (s, 1H). 13C NMR (CDCl3) d 42.3, 55.6, 114.0,
127.0, 128.2, 129.9, 130.5, 131.0, 131.5, 132.0, 136.4, 161.4,
162.2, 171.5. m/z: 267 (m+1). Anal. calcd. for C16H14N2O2:
C, 72.17; H, 5.30; N, 10.52; found: C, 72.25; H, 5.64; N, 10.90.
5.5. General procedure for synthesis of compounds 12a,b
A mixture of compound 11a (100 mg, 0.424 mmole), cesium
carbonate (152 mg, 0.466 mmole) in tetrahydrofuran (1 mL)
and chloro-2-methoxy ethane (31 lL, 0.466 mmole) or benzyl
chloride (56 lL, 0.466 mmole) was irradiated in microwave
at 120 C for 45 min. The solvent was evaporated and the resi-
due was purified by flash chromatography using ethyl acetate/
heptane 50% to give compound 12a or 12b. The reaction could
be performed also using sodium hydride (11 mg, 0.466 mmole)
in dimethylformamide (1 mL).
3-(2-Methoxyethyl)-1-phenyl-2,3-benzodiazepin-4-one (12a):
oily (85%) 1H NMR (CDCl3) d 3.29 (s, 3H), 3.46–3.66 (m,
4H), 4.11 (br s, 2H), 7.24–7.28 (m, 1H), 7.32–7.37 (m, 1H),
7.42–7.49 (m, 4H), 7.53–7.58 (m, 1H), 7.64–7.66 (m, 2H). 13C
NMR (CDCl3) d 42.5, 49.5, 58.8, 69.9, 126.9, 127.9, 128.5,
129.4, 129.6, 130.3, 131.1, 132.1, 137.1, 138.1, 162.6, 167.9 m/z:
295 (m+1). Anal. calcd. for C18H18N2O2: %C, 73.45; H,
6.16; N,9.52; found: 73.80; H, 6.22; N,9.19.
3-benzyl-1-phenyl-2,3-benzodiazepin -4-one (12b): oily (84%)
1H NMR (CDCl3) d 3.39–3.63 (m, 2H), 4.79–5.23 (m, 2H),
7.07–7.17 (m, 5H), 7.19–7.37 (m, 7H), 7.41–7.48 (m, 2H). 13C
NMR (CDCl3) d 42.5, 53.7, 126.9, 127.3, 127.9, 128.2, 128.5,
128.7, 129.5, 130.4, 131.1, 132.2, 137.1, 137.6, 138.0, 163.3,
167.8. m/z: 327 (m+1). Anal. calcd. for C22H18N2O: C,
80.96; H, 5.56; N,8.58; found: C, 80.95; H, 5.56; N, 8.60.
5.6. Tert-butyl(3-oxo-1-phenylisoquinolin-2(3H)-yl)carbamate(13)
Method A: A mixture of compound 10a (467 mg, 1.94 mmole),
N-methyl morpholine (433 mg, 4.270 mmole), and BOP(946 mg, 2.130 mmole) was dissolved in dichloromethane.
The mixture was stirred for 10 min at room temperature then
tert-butyl-carbazate (257 mg, 2.138 mmole) was added and the
reaction was stirred at room temp for 4 h. The solvent was
evaporated under reduced pressure and the residue was diluted
with ethyl acetate and washed with 1 N HCl, saturated solu-
tion of Na2CO3 and saturated solution of sodium chloride.
The organic layer was then dried over anhydrous sodium
sulfate, filtered, and evaporated under reduced pressure to
dryness. The residue was purified by column chromatography
using ethyl acetate/heptane 1:1 to give yellow microcrystal 13
in 83% yield.
Method B: EDCI, HCl (315 mg, 2.333 mmol) and triethy-
lamine (812 lL, 5.831 mmol) were added to a solution of
tert-butyl-carbazate (257 mg, 2.138 mmol), 10a (467 mg,
1.944 mmol) and HOBt (946 mg, 2.130 mmol) in dimethylfor-
mamide (25 mL) and stirred for 7 h at room temperature under
nitrogen. The solvent was evaporated under reduced pressure
and the residue was diluted with ethyl acetate and washed with
1 N HCl, saturated solution of Na2CO3 and saturated solution
of sodium chloride. The organic layer was then dried over
anhydrous sodium sulfate, filtered, and evaporated under
reduced pressure. The residue was purified by column chro-
matography using ethyl acetate/heptane 1:1 to give compound
13 in 95% yield.
White microcrystal, m.p. = 181–183 C; 1H NMR (CDCl3)
d 1.34 (s, 9H), 6.77–6.84 (m, 2H), 7.02–7.05 (m, 1H), 7.23–7.35
(m, 3H), 7.47–7.56 (m, 3H), 8.16 (s, 1H). 13C NMR (CDCl3) d
28.0, 82.8, 109.4, 117.0, 122.6, 125.3, 128.1, 128.4, 129.5, 129.7,
130.1, 131.7, 131.9, 143.5, 153.5, 159.3. m/z: 337 (m+1). Anal.
calcd. for C20H20N2O3: C, 71.41; H, 5.99; N, 8.33; found: C,
71.42; H, 5.98; N, 8.33.5.7. 2-(2-cyanophenyl)acetic acid (14): (Tang et al., 2010)
A mixture of compound 3d (442 mg, 1.692 mmole) and lithium
hydroxide (227 mg, 5.412 mmole) in methanol (4 mL) and
water (2 mL) was irradiated in microwave at 120 C for
5 min. The reaction was diluted in water and saturated solu-
tion of NaHCO3, and extracted with dichloromethane. The
aqueous layer was acidified with Conc. HCl to PH 2, and
extracted with dichloromethane; the organic layer was dried
over Na2SO4, filtered and evaporated under reduced pressure
to give white microcrystal 14 in 81% yield, m.p.: 103–105 C.
1H NMR (CD3OD) d 3.87 (s, 2H), 7.42–7.50 (m, 2H), 7.60–
7.73 (m, 2H). 13C NMR (CD3OD) d 40.4, 114.6, 118.6,
129.0, 132.2, 133.9, 134.3, 140.0, 173.5.
Tert-butyl 2-benzyl-2-(2-(2-cyanophenyl)acetyl)hydrazinecar
boxylate (16): A mixture of compound 14 (100 mg,
0.621 mmole), triethylamine (190 lL, 1.365 mmole) and BOP
(302 mg, 0.683 mmole) in dichloromethane (2 mL) was stirred
at room temperature for 3 min. Then, tert-butyl
2-benzylhydrazinecarboxylate (138 mg, 0.621 mmole) was
added and the mixture was stirred at room temperature for
14 h. The mixture was diluted with DCM, washed with satu-
rated solution of NaHCO3, and purified by flash chromatogra-
phy (ethyl acetate/heptanes 40%) to give oily compound 16 in
70% yield. 1H NMR (CDCl3) d 1.35 (s, 9H), 3.72–3.77 (m,
1H), 4.06–4.11 (m, 2H), 5.21–5.37 (m, 1H), 6.44 (s, 1H),
7.17–7.56 (m, 9H). 13C NMR (CDCl3) d 28.2, 38.1, 50.8,
82.6, 113.4, 118.0, 127.6, 128.2, 129.0, 129.2, 131.1, 132.7,
S1982 M.A. Ibrahim132.9, 135.2, 139.3, 154.1, 171.9. Anal. calcd. for C21H23N3O3:
C, 69.02; H, 6.34; N, 11.50; found: C, 69.01; H, 6.33; N, 11.51.
N-benzyl-2-(2-cyanophenyl)acetohydrazide (17): Compound
16 (50 mg, 0.136 mmole) was dissolved in trifluoroacetic acid
(2 mL) for 5 min. Trifluoroacetic acid was evaporated; the resi-
due was diluted in ethyl acetate, washed with saturated solu-
tion of NaHCO3, dried over Na2SO4, filtered, evaporated,
and purified by flash chromatography ethylacetate/heptanes
1:1 to give compound 17 in 90% yield. m.p.: 120–122 C. 1H
NMR (CDCl3) d 3.68 (br s, 2H), 4.25 (br s, 2H), 4.77 (br s,
2H), 7.25–7.48 (m, 7H), 7.44–7.66 (m, 2H). 13C NMR (CDCl3)
d 38.7, 53.4, 113.6, 118.3, 127.2, 128.2, 128.6, 128.7, 129.1,
130.7, 132.8, 135.4, 140.6, 172.0. Anal. calcd. for
C16H15N3O: C, 72.43; H, 5.70; N, 15.84 found: C, 72.45; H,
5.71; N, 15.80.
3-benzyl-1-imino-1,2,3,5-tetrahydro-4H-benzo[d][1,2]diaze
pin-4-one (18): Compound 17 (50 mg, 0.188 mmole) dissolved
in trifluoroacetic acid (1 mL) was irradiated in microwave at
120 C for 5 min. Trifluoroacetic acid was evaporated under
reduce pressure and the residue was purified by flash chro-
matography ethylacetate/heptanes 1:1 to give compound 18
in 10% yield. 1H NMR (CDCl3) d 3.08 (br s, 1H), 3.70 (br s,
2H), 4.62 (br s, 1H), 5.31 (br s, 2H), 7.23–7.29 (m, 3H),
7.32–7.42 (m, 3H), 7.48–7.74 (m, 3H). 13C NMR (CDCl3) d
39.0, 51.6, 127.4, 127.6, 128.5, 128.7, 129.1, 130.8, 132.6,
132.8, 136.3, 139.2, 162.2, 167.7. m/z: 266 (m+1). Anal. calcd.
for C16H15N3O: C, 72.43; H, 5.70; N, 15.84 found: C, 72.44; H,
5.69; N, 15.83.
5.8. Tert-butyl (1-((2-(2-cyanophenyl)acetyl)imino)-3-
hydroxyisoquinolin-2(1H)-yl)carbamate (21)
A mixture of compound 19 (100 mg, 0.621 mmole), BOP
(302 mg, 0.683 mmole), and triethylamine (190 lL,
1.365 mmole) in dichloromethane (4 mL) was stirred at room
temperature for 3 min at room temperature then tert-butyl
carbazate (82 mg, 0.621 mmole) was then added and the mix-
ture was stirred at room temperature for 14 h. The reaction
was diluted with dichloromethane and washed with saturated
solution of Na2CO3. The organic layer was then dried over
anhydrous sodium sulfate, filtered, and evaporated under
reduced pressure to dryness. The residue was purified by flash
chromatography ethyl acetate/heptanes 80% to obtain yellow
microcrystal 21 in 75% yield. m.p = 183–185 C.
1H NMR (CD3OD) d 1.56 (s, 9H), 4.64 (s, 2H), 7.11–7.15
(m, 1H), 7.34–7.69 (m, 6H), 8.01 (d, J= 7.2 Hz, 1H), 8.99
(d, J= 8.7 Hz, 1H). 13C NMR (DMSO-d6) d 28.8, 50.2,
81.9, 108.4, 114.1, 119.2, 121.8, 124.4, 126.5, 127.5, 131.8,
133.0, 133.4, 135.2, 141.2, 143.4, 155.7, 159.0, 159.3, 193.8.
m/z: 417(m1). Anal. calcd. for C23H22N4O4: C, 66.02; H,
5.30; N, 13.39; found: C, 66.00; H, 5.34; N, 13.35.
5.9. Ethyl 2-hydroxy-1H-pyrrolo[3,2-b]pyridine-3-carboxylate
(22): (Dogan et al., 2015)
A mixture of compound 8a (50 mg, 0177 mmole) and iron
(29.7 mg, 0.537 mmole) in acetic acid 100% (1 mL) was irradi-
ated in microwave at 130 C for 15 min. Upon completion of
the reaction, dichloromethane (25 mL) was added and iron is
filtered on small piece of cotton. Dichloromethane was evapo-
rated on rotavap to residue and purified by flash chromatogra-phy using gradient of 100% DCM to 10% MeOH/DCM to
give scarlet red compound 22 in 95% yield.
1H NMR (DMSO-d6) d 1.25 (t, J= 8.9 Hz, 3H), 4.21
(q, J= 7.0 Hz, 2H), 6.77 (t, J= 7.0 Hz, 1H), 7.03
(d, J= 7.5 Hz, 1H), 7.50 (d, J= 6.2 Hz, 1H), 10.3 (s, 1H),
12.5 (s, 1H). 13C NMR (DMSO-d6) d 14.8, 58.0, 82.6, 111.4,
111.5, 125.6, 131.1, 143.1, 164.1, 165.2. m/z: 207 (m+1). Anal.
calcd. for C10H10N2O3: C, 58.25; H, 4.89; N, 13.59; found: C,
58.26; H, 4.91; N, 13.62.
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